SYNGR1 and Alzheimer disease: Despite the observed reduction in CPLX1, SYT1, SYNGR1 levels in AD OML, no significant reductions were detected in any other investigated molecular layers in AD compared to control cases (Fig. 2A–J) or between neuronal layers (see pictures in Fig. 1 and quantifications in Supplementary Fig. 2).